Lower Drug Costs for Families Act

Hozzl · 2025-04-11T12:42:19Z

Explore the details of Senate Bill 1186 Lower Drug Costs for Families Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

4/11/2025, 12:42 PM

Summary of Bill S 1186

Bill 119 s 1186, also known as the Prescription Drug Pricing Reform Act, aims to make changes to the way prescription drug prices are calculated and regulated under Medicare. The bill proposes amending title XVIII of the Social Security Act to require drug manufacturers to provide inflation rebates for drugs sold in the commercial market, in addition to those sold through Medicare.

One of the key provisions of the bill is changing the base year for calculating these rebates. Currently, drug manufacturers are required to provide rebates based on the average manufacturer price of drugs in 2016. The Prescription Drug Pricing Reform Act seeks to update this base year to reflect more recent pricing data, in order to ensure that rebates accurately reflect current market conditions.

By applying inflation rebates to drugs sold in the commercial market, the bill aims to address rising prescription drug costs and ensure that Medicare beneficiaries are not paying more for their medications than necessary. This change could potentially lead to lower drug prices for consumers and reduce overall healthcare spending. Overall, the Prescription Drug Pricing Reform Act seeks to increase transparency and accountability in the pharmaceutical industry, while also working to make prescription drugs more affordable for all Americans.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 1186

Bill S 1186 is currently in the status of Bill Introduced since March 27, 2025. Bill S 1186 was introduced during Congress 119 and was introduced to the Senate on March 27, 2025. Bill S 1186's most recent activity was Read twice and referred to the Committee on Finance. as of March 27, 2025

Bipartisan Support of Bill S 1186

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 1186

Primary Policy Focus

Health

Alternate Title(s) of Bill S 1186

A bill to amend title XVIII of the Social Security Act to apply prescription drug inflation rebates to drugs furnished in the commercial market and to change the base year for rebate calculations.A bill to amend title XVIII of the Social Security Act to apply prescription drug inflation rebates to drugs furnished in the commercial market and to change the base year for rebate calculations.

Start holding our government accountable!